default author photo

Julien Mazieres

Hôpital Larrey

Toulouse

France

SCHOLARLY PAPERS

2

DOWNLOADS

232

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Weekly Paclitaxel Plus Bevacizumab versus Docetaxel As Second- or Third-Line Treatment in Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Results of the IFCT-1103 ULTIMATE Study

Number of pages: 37 Posted: 29 Jun 2019
Alexis Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlesi, Gerard Zalcman, Patrick Dumont, Damien Pouessel, Claire Poulet, Sandrine Hiret, Adrien Dixmier, Patrick-Aldo Renault, Catherine Becht, Olivier Raffy, Charles Dayen, Julien Mazieres, Eric Pichon, Alexandra Langlais, Franck Morin, Denis Moro-Sibilot and Benjamin Besse
Université de Lille - Thoracic Oncology Department, CHITS Sainte Musse, Centre Hospitalier Général - Le Mans, Bergonié Institute, Aix Marseille Université, Hopital Bichat Claude Bernard, Centre Hospitalier - Chauny, University of Paris - Saint Louis Hospital, Centre Hospitalier Universitaire Lyon Sud, Institut de Cancérologie de l'Ouest, Centre Hospitalier Régional Orleans, Centre Hospitalier - Pau, Clinique de Clémentville, Centre Hospitalier Louis Pasteur, Centre Hospitalier - Saint Quentin, Hôpital Larrey, François Rabelais University - CHU Bretonneau - CHU Hôpitaux De Tours, Intergroupe Francophone de Cancérologie Thoracique, Intergroupe Francophone de Cancérologie Thoracique, CHU Grenoble-Alpes and Comité de Pathologies Thoraciques
Downloads 186 (407,391)

Abstract:

Loading...

NSCLC, paclitaxel, docetaxel, bevacizumab

2.

Deleterious Association between Proton Pump Inhibitor and Protein Kinase Inhibitor Exposure and Survival for Patients with Lung Cancer: A Nationwide Cohort Study

Number of pages: 29 Posted: 01 Dec 2023
Constance Bordet, Mahmoud Zureik, Yoann Zelmat, Margaux Lafaurie, Maryse Lapeyre-Mestre, Agnès Sommet, Julien Mazieres and fabien despas
Université de Toulouse - CHU de Toulouse, French National Health Insurance, Université de Toulouse - CHU de Toulouse, Université de Toulouse - CHU de Toulouse, University of Toulouse 3, Paul Sabatier University - Department of Medical and Clinical Pharmacology, Université de Toulouse - CHU de Toulouse, Hôpital Larrey and Université de Toulouse - CHU de Toulouse
Downloads 46 (1,109,210)

Abstract:

Loading...

Protein kinase inhibitor, Proton pump inhibitor, Interaction, lung cancer